At present there is no ‘ideal’ thin-film transistor technology for demanding display applications, such as organic light-emitting diode displays, that allows combining the low-temperature, solution-processability offered by organic semiconductors with the high level of performance achievable with microcrystalline silicon1. N-type amorphous mixed metal oxide semiconductors, such as ternary oxides Mx1My2Oz, where M1 and M2 are metals such as In, Ga, Sn, or Zn, have recently gained momentum because of their high carrier mobility and stability2, 3 and good optical transparency, but they are mostly deposited by sputtering. So far no route is available for forming high-performance mixed oxide materials from solution at low process temperatures <250 °C. Ionic mixed metal oxides should in principle be ideal candidates for solution-processable materials because the conduction band states derived from metal s-orbitals are relatively insensitive to the presence of structural disorder and high charge carrier mobilities are achievable in amorphous structures2. Here we report the formation of amorphous metal oxide semiconducting thin-films using a ‘sol–gel on chip’ hydrolysis approach from soluble metal alkoxide precursors, which affords unprecedented high field-effect mobilities of 10 cm2 V−1 s−1, reproducible and stable turn-on voltages Von≈0 V and high operational stability at maximum process temperatures as low as 230 °C.
Nanometer-sized particles of the chalcopyrite compounds CuInS 2 and CuInSe 2 were synthesized by thermal decomposition of molecular single-source precursors (PPh 3 ) 2 CuIn-(SEt) 4 and (PPh 3 ) 2 CuIn(SePh) 4 , respectively, in the noncoordinating solvent dioctyl phthalate at temperatures between 200 and 300 °C. The nanoparticles range in size from 3 to 30 nm and are aggregated to form roughly spherical clusters of about 500 nm in diameter. X-ray diffraction of the nanoparticle powders shows greatly broadened lines, indicative of very small particle sizes, which is confirmed by TEM. Peaks present in the XRD can be indexed to reference patterns for the respective chalcopyrite compounds. Optical spectroscopy and elemental analysis by energy dispersive spectroscopy support the identification of the nanoparticles as chalcopyrites.
The electronic structure of low temperature, solution-processed indium–zinc
oxide thin-film transistors is complex and remains insufficiently understood. As
commonly observed, high device performance with mobility >1 cm2
V−1 s−1 is achievable after annealing in air
above typically 250 °C but performance decreases rapidly when annealing
temperatures ≤200 °C are used. Here, the electronic structure of low
temperature, solution-processed oxide thin films as a function of annealing
temperature and environment using a combination of X-ray photoelectron spectroscopy,
ultraviolet photoelectron spectroscopy, and photothermal deflection spectroscopy is
investigated. The drop-off in performance at temperatures ≤200 °C to
incomplete conversion of metal hydroxide species into the fully coordinated oxide is
attributed. The effect of an additional vacuum annealing step, which is beneficial if
performed for short times at low temperatures, but leads to catastrophic device
failure if performed at too high temperatures or for too long is also investigated.
Evidence is found that during vacuum annealing, the workfunction increases and a
large concentration of sub-bandgap defect states (re)appears. These results
demonstrate that good devices can only be achieved in low temperature,
solution-processed oxides if a significant concentration of acceptor states below the
conduction band minimum is compensated or passivated by shallow hydrogen and oxygen
vacancy-induced donor levels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.